Premium
Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation
Author(s) -
BARRACLOUGH KATHERINE A,
STAATZ CHRISTINE E,
ISBEL NICOLE M,
MCTAGGART STEVEN J
Publication year - 2010
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/j.1440-1797.2010.01349.x
Subject(s) - medicine , immunosuppression , tolerability , kidney transplantation , pharmacodynamics , intensive care medicine , transplantation , immune system , therapeutic drug monitoring , pharmacology , drug , immunology , pharmacokinetics , adverse effect
Advances in immunosuppressive therapies have improved kidney transplant outcomes. However, immunosuppressant drug‐induced toxicities continue to reduce tolerability and impact patient and graft survival. A major ongoing challenge in kidney transplantation is to establish ways of tailoring immunosuppressant therapy so as to maintain efficacy while minimizing toxicity. Pharmacodynamic monitoring by direct measurement of immune cell function has the potential to personalize immunosuppression. The purpose of this review is to provide the clinician with an overview of the methodology and use of immune function monitoring in the field of kidney transplantation.